Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated February 04, 2025, titled "Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Press Release".
Press Release Feb 04 2025
Filed with NSE ·
6ix hasn’t read this filing yet.
Sun Pharmaceutical Industries Limited on 6ix
Earlier from Sun Pharmaceutical Industries
- Sun Pharma Presents LEQSELVI Data Highlighting Clinical Efficacy and Durability for Treatment of Alopecia Areata at the 2024 Fall Clinical Dermatology Conference
- Press Release Oct 25 2024
- Press Release Oct 15 2024
- Sun Pharma and Philogen enter into a global Exclusive Commercialization, License, and Supply Agreement for commercializing the specialty product FIBROMUN
- Press Release Oct 01 2024
Later from Sun Pharmaceutical Industries
- Press Release Feb 17 2025
- Sun Pharmaceutical Industries Limited Press Release Apr 07 2025
- Sun Pharmaceutical Industries Limited Press Release Apr 24 2025
- Sun Pharma and Moebius Medical Announce Dual Publications on MM-II's Phase 2b Clinical Trial Results and Mechanism of Action in Osteoarthritis and Cartilage
- Press Release May 08 2025
Follow Sun Pharmaceutical Industries into a list and get an email when it puts out news.
Follow Sun Pharmaceutical Industries